As a result, treatment with CB1 antagonist SR141716 had no effect on both tumor weight and volume (Figure 1C), whereas tumor-bearing C57BL/6J mice treated with CB2 antagonist SR144528 showed a significant reduction in tumor weight and volume as compared to vehicle-treated animals (Figure 1D). This evidence concerns the gene CNR2 and neoplasm.